[Supply and demand: the influence of energy metabolism on angiogenesis].
Sapieha
Przemyslaw
P
Zaniolo
Karine
K
Hamel
David
D
Joyal
Jean-Sébastien
JS
Chemtob
Sylvain
S
D000818:Animals; D003930:Diabetic Retinopathy / Q000503:physiopathology; D004734:Energy Metabolism; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D007231:Infant, Newborn; D007267:Injections; D007511:Ischemia / Q000503:physiopathology; D051379:Mice; D009389:Neovascularization, Pathologic / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000627:therapeutic use; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D015861:Retinal Neovascularization / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D012171:Retinal Vessels / Q000254:growth & development / Q000473:pathology; D012178:Retinopathy of Prematurity / Q000503:physiopathology; D019802:Succinic Acid / Q000378:metabolism; D014822:Vitreous Body
C531499:GPR91 protein, mouse; D034741:RNA, Small Interfering; D043562:Receptors, G-Protein-Coupled; D019802:Succinic Acid